2024    2023    2022    2021    2020    2019    2018    2017    2016   

2015

Articles

81 - 

The median effective analgesic dose (ED50) of ropivacaine in ultrasound-guided transversus abdominis plane block for analgesia in reversal of ileostomy: A double-blind up-down dose-finding study.

Maria Lahlou-Casulli, Cécile Chaize-Avril, Emmanuel Pouliquen, Véronique Desfourneaux, Jean-Xavier Mazoit, Yannick Malledant, Hélène Beloeil

The median effective analgesic dose (ED50) of ropivacaine in ultrasound-guided transversus abdominis plane block for analgesia in reversal of ileostomy: A double-blind up-down dose-finding study. European Journal of Anaesthesiology, 2015, 32 (9), pp.640-644.

DOI : https://doi.org/10.1097/EJA.0000000000000198

Pubmed : 25485878

 

82 - 

Le thiopental n’est pas un facteur de risque de pneumopathie tardive chez le traumatisé crânien grave. Une analyse post-hoc sur 441 traumatisés crâniens graves

Sigismond Lasocki, Karim Asehnoune, Philippe Seguin, Antoine Roquilly, Olivier Mimoz, Claire Dahyot, Yannick Mallédant, Jean-François Hamel

Anesthésie & Réanimation, 2015, 1S1 congrès SFAR 2015, 1, Supplement 1, pp.A6.

DOI : https://doi.org/10.1016/j.anrea.2015.07.009

 

83 - 

Efficacy and safety of 12 weeks versus 18 weeks of treatment with grazoprevir (MK-5172) and elbasvir (MK-8742) with or without ribavirin for hepatitis C virus genotype 1 infection in previously untreated patients with cirrhosis and patients with previous null response with or without cirrhosis (C-WORTHY): a randomised, open-label phase 2 trial.

Eric Lawitz, Edward Gane, Brian Pearlman, E. Tam, Wayne Ghesquiere, Dominique Guyader, Laurent Alric, Jean-Pierre Bronowicki, Laura Lester, William Sievert, Reem Ghalib, Luis Balart, Fredrik Sund, Martin Lagging, Frank Dutko, Melissa Shaughnessy, Peggy Hwang, Anita y M Howe, Janice Wahl, Michael Robertson, Eliav Barr, Barbara Haber

Efficacy and safety of 12 weeks versus 18 weeks of treatment with grazoprevir (MK-5172) and elbasvir (MK-8742) with or without ribavirin for hepatitis C virus genotype 1 infection in previously untreated patients with cirrhosis and patients with previous null response with or without cirrhosis (C-WORTHY): a randomised, open-label phase 2 trial. The Lancet, 2015, 385 (9973), pp.1075-86.

DOI : https://doi.org/10.1016/S0140-6736(14)61795-5

Pubmed : 25467591

 

84 - 

Les anesthésiques locaux stimulent l’apoptose des cellules de carcinome hépatocellulaire

Grégoire Le Gac, Cédric Coulouarn, Bruno Clément, Gaelle Angenard, Isabelle Cannie, Hélène Beloeil

Anesthésie & Réanimation, 2015, 1S1 congrès SFAR 2015, 1, Supplement 1, pp.A197--A198.

DOI : https://doi.org/10.1016/j.anrea.2015.07.302

 

85 - 

Transitioning from routine to on-demand test ordering in intensive care units: a prospective, multicentre, interventional study

P. Le Maguet, K. Asehnoune, L. M. Autet, T. Gaillard, S. Lasocki, O. Mimoz, D. Demeure Dit Latte, S. Gergaud, J. Morcet, Philippe Seguin, Yannick Malledant, M. Tanguy

British Journal of Anaesthesia, 2015, 115 (6), pp.941--942.

DOI : https://doi.org/10.1093/bja/aev390

Pubmed : 26582861

 

86 - 

Utilisation du rapport protéinurie/créatininurie à partir d’un échantillon urinaire pour l’évaluation de la protéinurie dans le myélome multiple

E. Le Mouel, T. Frouget, N. Collet, Caroline Moreau, O Decaux

La Revue de Médecine Interne, 2015, 72e CONGRÈS DE LA SOCIÉTÉ NATIONALE FRANÇAISE DE MÉDECINE INTERNE, Tours, 10-12 décembre 2015, 36, Supplement 2, pp.A140.

DOI : https://doi.org/10.1016/j.revmed.2015.10.088

 

87 - 

Non-invasive assessment of liver fibrosis in C282Y homozygous HFE hemochromatosis.

Ludivine Legros, Edouard Bardou-Jacquet, Marianne Latournerie, Anne Guillygomarc'H, Bruno Turlin, Caroline Le Lan, Yoann Désille, Fabrice Lainé, Romain Moirand, Pierre Brissot, Yves Deugnier, Dominique Guyader

Non-invasive assessment of liver fibrosis in C282Y homozygous HFE hemochromatosis. Liver International, 2015, 35 (6), pp.1731-1738.

DOI : https://doi.org/10.1111/liv.12762

Pubmed : 25495562

 

88 - 

Transcriptomic analysis of trout gill ionocytes in fresh water and sea water using laser capture microdissection combined with microarray analysis

Isabelle Leguen, Aurélie Le Cam, Jérôme Montfort, Sandrine Peron, Alain Fautrel

PLoS ONE, 2015, 10 (10), pp.1-22.

DOI : https://doi.org/10.1371/journal.pone.0139938

Pubmed : 26439495

 

89 - 

Pomalidomide plus low-dose dexamethasone in multiple myeloma with deletion 17p and/or translocation (4;14): IFM 2010-02 trial results.

Xavier Leleu, Lionel Karlin, Margaret Macro, Cyrille Hulin, Laurent Garderet, Murielle Roussel, Bertrand Arnulf, Brigitte Pegourie, Brigitte Kolb, Anne Marie Stoppa, Sabine Brechiniac, Gerald Marit, Beatrice Thielemans, Brigitte Onraed, Claire Mathiot, Anne Banos, Laurence Lacotte, Mourad Tiab, Mamoun Dib, Jean-Gabriel Fuzibet, Marie Odile Petillon, Philippe Rodon, Marc Wetterwald, Bruno Royer, Laurence Legros, Lotfi Benboubker, Olivier Decaux, Martine Escoffre-Barbe, Denis Caillot, Jean Paul Fermand, Philippe Moreau, Michel Attal, Herve Avet-Loiseau, Thierry Facon

Pomalidomide plus low-dose dexamethasone in multiple myeloma with deletion 17p and/or translocation (4;14): IFM 2010-02 trial results. Blood, 2015, 125 (9), pp.1411-7.

DOI : https://doi.org/10.1182/blood-2014-11-612069

Pubmed : 25575538

 

90 - 

Lack of drug interaction between cyclosporine and telaprevir in a liver transplant recipient

F. Lemaître, C. Jézéquel, M.-C. Verdier, M. Dermu, C. Boglione-Kerrien, K. Boudjema, E. Bellissant

Transplant Infectious Disease, 2015, 17 (1), pp.106--110.

DOI : https://doi.org/10.1111/tid.12335

Pubmed : 25573697